Narval
A new generation of antibody drugs using synthetic antibody mimetic proteins delivered through mucosal and skin tissues
8 employees · est. 2023 · Knoxville, United States
SAB BIO
Working to transform treatment for people living with type 1 diabetes through a unique disease-modifying therapy
88 employees · est. 2014 · Miami, United States
SAB BIO is the older company (2023 vs 2014); SAB BIO is the larger of the two.
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | Narval | SAB BIO |
|---|---|---|
| Founded | ||
| Founded | 2023 | 2014 older |
| Headquarters | ||
| Headquarters | Knoxville, United States | Miami, United States |
| Employees | ||
| Employees | 8 | 88 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Non Equity Assistance | Post Ipo Equity |
| Total Funding | ||
| Total Funding | Not tracked yet | $186.32M |
| Funding Rounds | ||
| Funding Rounds | 1 | 7 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceuticals, Immunotherapeutics, Antibody Engineering, Antibody Drugs, Disease Treatment, Respiratory Diseases, Eye Diseases, Autoimmune Diseases, Skin Diseases, Mucosal Delivery, Skin Delivery, Antibody Mimetic Proteins, Immunotherapy, Life Sciences | Biopharmaceuticals, Immunotherapy, Type 1 Diabetes, Clinical-stage, Disease-modifying, Antibody Therapeutics, Immunoglobulins, Antibody Science, Immunology, Autoimmune Diseases, Public Health, Rare Conditions, Long-term Diseases, Pandemic Threats |
| Website | ||
| Website | narvalbio.com | sab.bio |
About Narval
Narval is a biotechnology startup founded in 2023, focusing on pioneering a new generation of antibody drugs using synthetic proteins that mimic the activity of antibodies. The company's slogan is "A new generation of antibody drugs using synthetic antibody mimetic proteins delivered through mucosal...
About SAB BIO
SAb Biotherapeutics is a biotechnology startup founded in 2014 and headquartered in the United States. The company is dedicated to developing a disease-modifying immunotherapy aimed at delaying the onset and progression of type 1 diabetes. They have a novel immunotherapy platform focused on developi...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Narval and SAB BIO — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Narval and SAB BIO — by email.
Frequently Asked Questions
Compare Narval with someone else
Start typing a company name or domain.